Increasing awareness of diabetes and obesity treatments propels demand for effective treatments, such as GLP-1 receptor agonists
Extrapolating from tendon data and mechanisms suggests bone healing likely benefits though direct confirmation limited
Retatrutide NAFLD - Phase 2 Trial Results in Subset of Patients with Obesity and NAFLD
Biochem J 475:959976 Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, Lim PB, McNarry M, Morten K, OSullivan O, Pretorius E, Raman B, Soteropoulos DS, Taquet M, Hall CN (2023) Long covid: mechanisms, risk factors and recovery
Theoretical Benefits: Weight Loss and Inflammation GLP-1 agonists are primarily approved for weight loss and diabetes management
Keep in mind that some medications for these conditions such as insulin, sulfonylureas, or certain beta-blockers can contribute to weight gain